We tested the hypothesis that the irreversible c-amino butyric acid transaminase inhibitor, c-vinyl c-amino butyric acid [vigabatrin (VGB)], would reduce ethanol reinforcement and enhance the discriminative-stimulus effect of ethanol, effectively reducing ethanol intake. The present studies used adult C57BL/6J (B6) mice in well-established operant, two-bottle choice consumption, locomotor activity, and ethanol discrimination procedures to comprehensively examine the effects of VGB on ethanol-supported behaviors. VGB dose-dependently reduced operant responding for ethanol and ethanol consumption for long periods of time. Importantly, a low dose (200 mg/kg) of VGB was selective for reducing ethanol responding without altering the intake of food or water reinforcement. Higher VGB doses (> 200 mg/kg) reduced ethanol intake, but also significantly increased water consumption and, more modestly, increased food consumption. Although not affecting locomotor activity on its own, VGB interacted with ethanol to reduce the stimulatory effects of ethanol on locomotion. Finally, VGB (200 mg/kg) significantly enhanced the discriminative-stimulus effects of ethanol as evidenced by significant leftward and upward shifts in ethanol generalization curves. Interestingly, VGB treatment was associated with slight increases in blood ethanol concentrations. The reduction in ethanol intake by VGB appears to be related to the ability of VGB to potentiate the pharmacological effects of ethanol.
Introduction
Alcohol is one of the most commonly abused drugs in society. A recent publication based on the National Epidemiological Survey on Alcohol and Related Conditions database indicated that almost 18 million adults in the United States meet the diagnostic criteria for alcohol abuse or alcohol dependence (Grant et al., 2004) . In fact, excessive alcohol (ethanol) consumption is estimated to be the third leading cause of preventable death in the USA (Mokdad et al., 2004) . For these and a variety of other reasons, considerable effort has been expended to understand the complex nature of this rather simple molecule, which, in moderation, can have beneficial effects (White, 1996; Agarwal, 2002) ; however, with prolonged and excessive exposure can be quite deleterious (Ringborg, 1998; Seitz and Becker, 2007; Zakhari and Li, 2007; Beier et al., 2011) . A wealth of knowledge regarding the pharmacology and neurobiological effects of ethanol derives from several decades of research using various animal models, in conjunction with pharmacological agents. These studies have established that several central neurotransmitter systems are important for regulating ethanol intake and discrimination, with g-amino butyric acid (GABA), glutamate, serotonin, and dopamine systems being parti-cularly important. Although all of these neurotransmitter systems are important in the effects of ethanol, the GABAergic system is of particular interest because ethanol directly potentiates chloride conductance through inotropic GABA A receptors (Burch and Ticku, 1980; Morrow et al., 1988a Morrow et al., , 1988b . In addition, data from the Collaborative Study on the Genetics of Alcoholism found that certain single nucleotide polymorphisms in the GABA A receptor in humans are positively correlated with the development of alcoholism (Edenberg et al., 2004) . Importantly, this finding has been substantiated by several additional reports examining the relationship between ethanol-related behaviors and the GABA A receptor (Dick et al., 2006; Bauer et al., 2007; Xuei et al., 2010) .
Using mouse models of ethanol drinking, we have found that ethanol concentrations in the nucleus accumbens increase over the course of the drinking session and that licking behavior declines with increased ethanol concentration (Griffin et al., 2007 (Griffin et al., , 2009 ). These results suggest that the presence of ethanol within the nucleus accumbens can reduce ethanol intake, perhaps by the direct activation of GABA A receptors and subsequent neuronal inhibition within the nucleus accumbens. Indeed, a microinjection of muscimol, a GABA A agonist, into the nucleus accumbens can reduce responding for ethanol (Hodge et al., 1995) and also substitute for the discriminative-stimulus effects of ethanol in a classic drug discrimination procedure (Hodge and Cox, 1998) . Together, these findings are consistent with a general hypothesis that ethanol within the nucleus accumbens participates in the ethanol discriminative cue and may serve as a stop signal for ethanol consumption when it reaches sufficient concentrations during a drinking session, perhaps acting through GABA A receptors. Recent evidence also indicates an important role for GABA B receptors in regulating ethanol consumption (Colombo et al., 2004; Tanchuck et al., 2011) , acting perhaps within the nucleus accumbens (Steffensen et al., 2000) but also the ventral tegmental area (Moore and Boehm, 2009 ) to affect drinking. Thus, in general, the GABAergic system function appears to be critical for the processes mediating ethanol's reinforcing and discriminative properties, which are important for the maintenance of ethanol drinking.
In the present study, we investigated the effects of an irreversible GABA agonist, g-vinyl GABA [vigabatrin (VGB)], on several different ethanol-related behaviors of C57BL/ 6J (B6) mice to further elucidate the influence of the GABAergic system on ethanol reinforcement and discrimination. VGB elevates brain GABA concentrations by its irreversible inhibition of GABA transaminase (Valdizan and Armijo, 1992) . Upon contact with the transaminase, VGB is transformed into a highly reactive intermediate compound that binds covalently to an active site on the protein, resulting in irreversible inhibition. The in-vivo consequences of this action are long-lasting increases in GABA concentrations (Jung et al., 1977; Gram et al., 1989; Rey et al., 1992) . Previous reports indicate that VGB prevents the increase in extracellular dopamine in the nucleus accumbens produced by injections of cocaine (Dewey et al., 1998) , nicotine ), methamphetamine, heroin, or ethanol (Gerasimov et al., 1999 and also reduces ethanol consumption by AA rats (Wegelius et al., 1993) . These reports suggest that increasing GABAergic neurotransmission by irreversibly blocking GABA transaminase alters the reinforcing effects of abused drugs. In addition, activation of GABA A receptors, which occurs with irreversible GABA transaminase blockade, plays a critical role in the discriminativestimulus effects of ethanol (Hodge and Cox, 1998; Grant, 1999) . Therefore, in the present study, we hypothesized that VGB would dose-dependently reduce ethanol reinforcement and enhance the discriminative-stimulus effect of ethanol, effectively reducing ethanol intake.
Methods

Subjects
All subjects were male C57BL/6J (B6) mice obtained at approximately 7 weeks of age from the Jackson Laboratory (Bar Harbor, Maine, USA) and individually maintained in standard cages with wood-chip bedding in AAALACaccredited colony rooms at the Medical University of South Carolina. Mice were acclimated to the new environment for at least 1 week before beginning any experiment. All procedures were approved for use by the Institutional Animal Care and Use Committee of Medical University of South Carolina.
Apparatus
Self-administration
Mice were tested in chambers with stainless-steel grid floors enclosed in light-controlled and sound-controlled boxes as previously described in detail Price and Middaugh, 2004; Nguyen et al., 2005) . Briefly, the computercontrolled chambers recorded the number of presses at a single lever and licking behavior (i.e., contacts) at a brass fountain that delivered 60 ml ethanol when response contingencies were met. Unconsumed ethanol was measured and subtracted from the amount delivered to provide the amount of ethanol consumed. Finally, the sipper tube from a 50 ml water bottle protruded into the chamber to provide free access to water. Licking behaviors were measured at the sipper tube and water volumes consumed from the bottle were determined after adjusting for spillage collected under the spout.
Ethanol discrimination
Mice were tested in six gray Plexiglas two-lever chambers with a food pellet dispenser as previously described (Middaugh et al., 1988 (Middaugh et al., , 2000a Groseclose and Middaugh, 1997) . Food pellet (20 mg A/I Rodent Pellets; Noyes Co., Lancaster, New Hampshire, USA) reinforcers were delivered to a tray located at the floor level. Levers were located on each side of the tray.
Self-administration (Experiment-1) Experiment (Exp)-1 was conducted in three phases over a 9-month period as previously described (Price and Middaugh, 2004) . These procedures will reliably yield blood ethanol concentrations (BECs) in excess of 100 mg% and the mice are visibly intoxicated, once responding has stabilized, as previously reported Middaugh et al., 2000a Middaugh et al., , 2000b . The mice were maintained on a 12-h light cycle (on 07:00 h). At all times, mice were maintained at 85% (range: 82-87%) free-feeding bodyweights by restricting feeding to a single daily ration. Mice were tested in 15-min sessions (5 days per week Monday-Friday) between 08:00 and 12:00 h. During the first phase, the mice acquired the lever response and the fixed ratio (FR) requirements were increased from FR1 to FR4 over 12 weeks, with mice being reinforced with a final ethanol concentration of 12% under the prefeeding condition (i.e. testing before the daily food ration). The final stage of phase 1 included 1 week of testing under the FR4 schedule to examine the influence of systematic changes in ethanol concentration (0, 3, 6, and 12% in ascending order) compared with water on lever pressing.
Phase 2 of Exp-1 determined the effects of VGB on responding for ethanol during prefeeding tests with 12% ethanol delivered on a FR4 schedule. Mice were habituated to subcutaneous (s.c.) injections of vehicle (VEH) for 1 week. Over the next 5 weeks, the effects of VGB were examined. During the first and fifth weeks, mice were injected with VEH before each daily test. During weeks 2-4, mice were injected with VGB (200, 400, and 600 mg/kg) each Wednesday and VEH on the other 4 days of the week. The VGB dosing order was counterbalanced across three subgroups of mice (n = 6/group).
Phase 3 of the study evaluated the selectivity of the effects of VGB on ethanol responding by examining lever responding for water and then food. In the first part of this phase, mice were maintained on the same ethanol reinforcement schedule (12% ethanol on FR4) but switched to postfeeding test sessions (i.e. tested after being fed their daily food ration without water availability to increase thirst). After 3 weeks of habituation to this new schedule, the effects of VGB were evaluated when reinforcement was either 12% ethanol or water. During these tests, occurring on the Wednesday of 2 successive weeks, mice were divided into two groups with equivalent mean response output on the preceding day (Tuesday). One of the groups was injected with VGB (200 mg/kg) and the other with VEH. Water served as the reinforcer on Wednesday during the first week and 12% ethanol on Wednesday during the second week (all other days of the week, 12% ethanol was the reinforcer). During the tests in which water served as the reinforcer, we originally intended to include 12% ethanol as the alternative liquid, available through the sipper tube. However, this was discontinued after two mice overdosed on the freely available ethanol during the first test and no alternative fluid was available for the remainder of phase 3. To assess the effects of VGB on food reinforcement, mice were acclimatized over a 3-week period to another similar set of selfadministration chambers but lever responded for 45 mg Noyes food single food pellets from a pellet dispenser. After 1 day with food pellets delivered for each response, the schedule was increased to FR4 and for 3 weeks of adaptation to food reinforcement sessions. The mice were then divided into two groups with equal mean response output and injected with either saline (SAL) or VGB (200 mg/kg) 2.5 h before testing on Wednesdays. Data generated on these tests were compared with data generated by the same mice during their VGB 200 mg/kg tests with 12% ethanol as the reinforcement during phase 2.
Ethanol consumption (Experiment-2)
For this experiment, mice were individually housed and maintained on a 12 h reverse light/dark cycle, lights off from 11:00 to 23:00 h, and given 21 h of access daily to ethanol (12% volume/volume) with water as the alternative choice, in a procedure previously described in detail (Nguyen et al., 2005) . The amounts of ethanol, water, and food consumed were determined by weighing the food and the tubes containing either water or ethanol before and after the daily 21 h observation periods (08:00 h). Fluid volumes were corrected for spillage and/or evaporation, on the basis of weight loss of control tubes maintained on empty cages. Unconsumed food was not determined but was not obvious on the floor of the cages.
After 2 weeks of access in the two-bottle choice procedure, the mice were distributed into three groups (n = 10 per group) with equivalent daily ethanol intake levels. Over the following 9 days, mice were injected (s.c.; 2.5 h prior to access), according to group assignment, with VEH, VGB (200 mg/kg), or VGB (600 mg/kg). Because the results of Exp-1 suggested that VGB was effective for 48-72 h, mice were injected with VEH or VGB on alternate days.
Locomotor activity (Experiment-3)
The effects of VGB on locomotor activity were examined on the same mice used for Exp-2. The most selective dose of VGB on ethanol reinforcement (200 mg/kg) was contrasted with the highest VGB dose (600 mg/kg). Locomotor activity was recorded at 15-min intervals using locomotor activity monitors (Accuscan Instruments, Columbus, Ohio, USA) as previously described (Halberda et al., 1997; Griffin and Middaugh, 2005; Griffin et al., 2010) . The initial assessment began the week following the consumption experiment (Exp-2) while the mice were still maintained on the ethanol consumption schedule. The mice were randomly assigned to three groups (VEH, VGB 200, and VGB 600 mg/kg) and locomotor activity tests began 2.5 h after the injections. Two additional assessments were conducted at 3 and 5 weeks, respectively, after termination of ethanol consumption using the same mice to evaluate the interactive effects of VGB and ethanol on locomotion. Mice were injected (s.c.) with VEH or VGB 2.5 h before injection [intraperitoneally (i.p.)] with ethanol or SAL. Five minutes after the ethanol injection, mice were evaluated for locomotor activity.
Ethanol discrimination (Experiment-4)
We have previously described our ethanol discrimination procedures (Groseclose and Middaugh, 1997; . In brief, mice were individually housed and maintained on a 12-h light cycle (lights on 06:00 h) and testing occurred 13:00-16:00 h, Monday-Friday. Bodyweights were maintained at 85% (range: 82-87%) of freefeeding weight and the single daily food ration was given after testing.
After reducing bodyweights, lever responding was established and the reinforcement schedule was gradually increased to FR20. After stable responding, ethanol discrimination training was initiated, with mice injected i.p. 5 min before the session. Ethanol (1 g/kg) and VEH injections were alternated on a semirandom schedule with no more than 2 successive days of either ethanol or VEH, with the number of injections of each being equal over a 10-day period. Responses on a designated lever were reinforced following ethanol injections and responses on the opposite lever were reinforced after VEH injections, which was counterbalanced across mice. Responses were recorded and a discrimination index (DI) was calculated (DI = the number of responses on the correct lever/total responses before delivery of the first reinforcer).
After meeting the discrimination criterion (DI = 85% on 3 consecutive days), ethanol dose-response functions were established using a cumulative dosing procedure involving a series of injections and tests within the same session Crissman et al., 2004) , although correct responses were not reinforced, consistent with our previous reports (Groseclose and Middaugh, 1997; . To accomplish this, mice were initially injected with VEH and, after 5 min, were placed in the operant chamber for a 2 min test with no reinforcement for responses on either lever. The first test was followed rapidly by five additional 2 min tests, each occurring 5 min after an ethanol injection of 0.5 g/kg, producing a total cumulative dose of 2.5 g/kg (series 1). After returning to training and meeting the performance criterion on subsequent sessions, the mice were subjected to a second series of tests as before using 0.25 g/kg ethanol (series 2; for a total cumulative dose of 1.25 g/kg). Thus, during either series 1 or 2, including the initial injection of VEH each mouse had a series of six tests within 45 min designed to produce increasing BECs, as previously described Crissman et al., 2004) . The cumulative dosing procedure was conducted 2.5 h after s.c. injections of either VEH or VGB (200 mg/kg).
Blood ethanol concentration measurements
Blood was collected from the retro-orbital sinus of mice injected with either SAL or VGB 5 min after the final 0.25 g/kg ethanol injection in the ethanol discrimination experiment. Blood was not collected after the 0.5 g/kg test (series 1). The blood sampling and gas chromatography assay procedures to determine ethanol concentration were according to previously published techniques (Middaugh and Gentry, 1992c; Griffin et al., 2009) .
Drugs
Ethanol (95%) was obtained from AAPER (Shelbyville, Kentucky, USA). When used for oral consumption, ethanol was mixed in a volume/volume ratio to yield the desired concentration. When ethanol was given i.p., it was mixed in water at a concentration of 12.3% and administered in a volume of 0.02 ml/g bodyweight. VGB was manufactured by Aventis Pharma Inc. (Laval, Quebec, Canada) and was obtained from Murray Shore Pharmacy (Toronto, Ontario, Canada) in sachets containing 500 mg of powder. VGB was mixed with 0.9% NaCl (normal SAL) and administered s.c. in a volume of 0.01 ml/g bodyweight. In all experiments, VGB was given 2.5 h before testing on the basis of previous reports (Jung et al., 1977; Kushner et al., 1999) .
Statistical analysis
The experiments described in the present report had a variety of dependent variables, which were analyzed using analysis of variance (ANOVA), incorporating repeatedmeasures (RM) on some of the factors as necessary. Significant factor interactions were followed up using post-hoc analysis as described in the results section. Nonlinear curve fitting to calculate the ED 50 values was carried out using GraphPad Prism Version 5 (GraphPad Software, La Jolla, California, USA). For all analyses, significance was considered as P value less than 0.05.
Results
Experiment-1: effects of vigabatrin on ethanol self-administration
This experiment used 24 male C57BL/6J (B6) mice. During the acquisition phase, four mice of 24 that started did not acquire the lever pressing behavior and were excluded from further testing.
Phase 1
In the final stage of training, lever responses and licks were evaluated during separate test days for water, three ethanol concentrations, and again for water (i.e. 0, 3, 6, 12, and 0%). The lever presses (mean ± SEM) were 62 ± 4 for the combined water days, and 64 ± 3, 73 ± 9, and 86 ± 8, respectively, for the 3, 6, and 12% ethanol concentrations. Comparable data for the lick measure were 83 ± 11 for the water days, and 123 ± 20, 172 ± 30, and 298 ± 32 for the increasing ethanol concentrations. One-way RM ANOVA across the four concentrations (0, 3, 6, 12%) indicated significant increases in response frequency for lever presses [F (3,60) = 4.84, P < 0.005] and licks [F (3,60) = 36.06, P < 0.001]. Post-hoc Duncan's tests indicated that lever responses and licks at the fountain were greater for 12% ethanol than for the other solutions (both P values < 0.01). Thus, lever presses and licks increased with increasing ethanol concentration and then decreased when water was provided again. These data are consistent with our previous report indicating that ethanol, rather than fluid per se, influenced appetitive behavior.
Phase 2: effects of vigabatrin on responding for ethanol
Once ethanol-reinforced responding was established, we evaluated the effects of VGB on ethanol-reinforced responding over a 5-week period. Our first analysis was to determine whether the different dose orders (see methods; 400, 600; 600, 200; 200, 400) impacted any of the measures. The data collected on the drug test days (Wednesdays) were evaluated with 3 (VGB Dose Order) Â 4 (Dose) mixedfactor ANOVAs, with RM on the Dose factor. ANOVA results, summarized in Table 1 , indicated no effect of the dose order on any of the dependent variables except ethanol intake. Additional post-hoc analyses on the intake data did not reveal specific reasons for this, although the effect of dose order on the 200 mg/kg dose did approach significance in one category [Order II (2.88 ± 0.45) > Order III (1.20 ± 0.33), Newman-Keuls, P = 0.056]. Thus, it was concluded that dosing order did not meaningfully influence the dependent variables measured in this experiment.
The data from Exp-1 are summarized in Interestingly, and in contrast to ethanol responses which declined, with increasing VGB dose, licking behavior at the sipper tube that allowed free access to water (methods Exp-1) tended to increase, as follows: 0 mg/kg VGB 16 ± 4; 200 mg/kg VGB 10 ± 2; 400 mg/kg VGB 33 ± 12; and 600 mg/kg VGB 37 ± 10. The one-way ANOVA was significant [F (3, 48) = 4.25, P r 0.05] and post-hoc Dunnett's tests indicated a significant elevation for the highest dose compared with the VEH mean (P r 0.01). The mean water intake (ml) from the sipper tube also tended to increase (ranging from 0.5 to 1.8 ml), but this did not reach statistical significance [F (3,48) = 1.97, NS]. Together, these data indicate that mice shifted their preference away from ethanol reinforcement to water reinforcement when VGB was administered.
We also specifically examined whether VGB could alter ethanol self-administration during subsequent sessions of ethanol access by analyzing data from test sessions following VGB administration. First, the data collected during daily sessions 1 week before and 1 week after the three VGB test weeks were analyzed using 2 (Test Week) Â 5 (Days) RM ANOVAs to determine whether VGB exposure during the intervening test weeks affected behavioral measures of interest. These analyses (Table 2) indicated that data collected during the weeks of VEH injections before versus after the drug tests did not differ for any measures, except for average amounts of ethanol consumed, which were slightly greater during the posttest week. Therefore, the average of these 2 weeks of data was taken as a baseline measure for subsequent analysis. Data generated on daily sessions during each week were examined with 4 (Dose Week) Â 5 (Days) RM ANOVAs. The analyses are summarized in Table 3 and the data are summarized in Fig. 1d-f . As shown, lever responses ( Fig. 1d ), fountain licks (Fig. 1e ), and ethanol intake ( Fig. 1f ) varied across days depending on the particular VGB dose administered (Dose Week Â Days interaction). These data were further analyzed using oneway RM ANOVAs, followed by Dunnett's tests comparing responses on the day before drug tests with data collected on the drug test session and postdrug test sessions. Significant VGB effects (P < 0.05) were observed for 2 days after the drug test for the lever response (Fig. 1d) , and on the following day for fountain licks (Fig. 1e ) and ethanol intake (Fig. 1f ).
Phase 3: effects of vigabatrin on ethanol versus food and water reinforcement
Ethanol versus food: the comparative effects of VGB on ethanol versus food reinforcement were determined by comparing lever response data for food reinforcement with data generated by the same mice for 12% ethanol during the VGB dose-response phase noted above (phase 2). Test conditions were identical for the two experiments, except for the differences in reinforcers. These data are summarized in the prefeeding portion of Fig. 2 , and were analyzed using a 2 (VGB) Â 2 (reinforcer) RM ANOVA. The ANOVA supported the interaction noted in the figure [F (1,18) = 12.585, P < 0.01]. Post-hoc analysis using pairwise comparisons found that VGB significantly reduced responses for ethanol, but not food (P < 0.05).
Ethanol versus water: the comparative effect of VGB on ethanol versus water reinforcement under postfeeding test conditions is summarized on the right-hand side of Fig. 2 . Mice used in the dose-response experiment were tested in a 2 (VGB) Â 2 (reinforcer) mixed-factor design with RM on the reinforcer factor. On the test day, nine mice were injected with VGB (200 mg/kg) and eight with SAL. An ANOVA confirmed the interaction of VGB and reinforcer type apparent in four bars on the righthand side of Fig. 2 [F (1,15) = 17.67, P < 001]. Pairwise post-hoc analysis indicated that the 200 mg/kg dose of VGB significantly reduced responses for ethanol but not water (P < 0.05). 
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Effects of vigabatrin (VGB) in C57BL/6J (B6) mice (n = 18) on lever responding for ethanol with concurrent free access to water. VGB was injected subcutaneously 2.5 h before the 15 min tests each Wednesday over a 3-week period, with vehicle injected before the other daily sessions. (a-c) VGB produced dose-responsive reductions in lever responding, licking behavior, and ethanol intake. (d-f) Lever responses for ethanol remained reduced for as long as 2 days, and licks and ethanol consumption for as many as 2 days, following VGB injections. Values are means ± SEM (*P < 0.05 compared with vehicle, + P < 0.05 compared with the Monday-Tuesday average). Figure 3 summarizes ethanol (g/kg), food (g), and water (ml/g) consumption on days when the drug was injected [noted as drug days (DD)] or not [noted as nondrug days (ND)]. The 5 days of drug injections versus the 4 days of no injection were averaged for each animal to provide the group-averaged data presented in Fig. 3 . Inspection of the graph indicates a dose-responsive reduction in ethanol consumption on the days of VGB injection (drug days) and the intervening days (ND). In contrast, mice injected with either dose of VGB showed no reduction in food and water consumption. In fact, mice injected with the highest VGB dose had elevated water consumption, and to a lesser extent, food consumption on ND. Mixed-factor 3 (VGB Dose) Â 2 (injection day) ANOVAs with RM on the injection day factor were used to analyze the data. ANOVA confirmed the VGB-induced reduction of ethanol consumption [VGB Dose: F (2,25) = 30.78, P < 0.001]. Importantly, the VGB Dose Â Injection Day interaction did not approach significance (F < 1.0), indicating that ethanol consumption was reduced for at least 48 h following injection. Comparison across the means of the three dose groups in Fig. 3 confirmed the differences between all three groups (Newman-Keuls tests, P < 0.01). In contrast, the ANOVA on water consumption indicated a significant VGB Dose Â Injection Day interaction [F (2,25) = 21.56, P < 0.001]. Post-hoc analysis indicated that mice injected with the 600 mg/kg dose of VGB consumed more water than the other groups on days when the drug was not injected (ND). The ANOVA on food consumption also indicated a significant VGB Dose Â Injection Day interaction [F (2,25) = 4.25, P < 0.05]. Post-hoc comparisons indicated a significant increase in food intake on the days following drug tests (ND) for mice injected with VGB 600 mg/kg compared with VEH treatment the day before (Dunnett's test, P < 0.02). Thus, treatment with VGB produced a long-lasting reduction in ethanol consumption that was coupled to increases in water and food consumption on nontreatment days.
Experiment-2: vigabatrin effects on ethanol consumption
Experiment-3: effects of vigabatrin and ethanol on locomotor activity
The results of this experiment are summarized in Fig. 4 . Total distance (cm) data were analyzed using a 3 (VGB Dose) Â 4 (Time 15-min interval ) mixed-factor ANOVA with RM on the time factor. Figure 4a indicates that at doses of 200 and 600 mg/kg, given s.c. 2.5 h before the assessment, VGB did not alter the total distance traveled over the hour according to either Dose [F (2,21) = 1.20, NS] or its interaction with time [F (6,67) = 1.47, NS]. Figure 4b and c summarize the results of two experiments conducted 3 ( Fig. 4b) and 5 ( Fig. 4c ) weeks, respectively, after termination of ethanol consumption. For the first test, summarized in Fig. 4b , the VGB and ethanol doses were 200 mg/kg and 2 g/kg, respectively. The 3 (Drug Condition) Â 4 (Time Interval) RM ANOVA on these data indicated significant effects of Drug Condition (F (2,15) = 3.48, P r 0.05) and its interaction with Time Interval (F (6,45) = 4.59, P r 0.001). Post-hoc one-way ANOVAs and mean comparisons at the four time points (Dunnett's test) comparing the two drug groups with Ethanol Ethanol Reinforcer
Food Water
Effects of vigabatrin (VGB) on lever responding for food and water in comparison with ethanol (n = 18). When responding for 12% ethanol or food pellet reinforcement and tested before the daily food ration (prefeeding condition), VGB 200 mg/kg selectively reduced responding for ethanol. Further, when responding for 12% ethanol or water reinforcement and tested after being fed the daily food ration (postfeeding condition), VGB 200 mg/kg selectively reduced responding for ethanol. All values are means ± SEM (*P < 0.05 compared with vehicle). SAL, saline.
(SAL + VEH) controls indicated that the 2 g/kg ethanol dose (SAL + ethanol 2) increased the total distance traveled during the first 15 min interval (P r 0.01), indicative of ethanol-induced stimulation as previously reported (Middaugh et al., 1992a; Griffin et al., 2010) . This ethanol-induced locomotor stimulation was blocked by pretreatment with the 200 mg/kg VGB dose (VGB + ethanol 2) that also significantly reduced motor activity during the second 15-min interval (VGB + ethanol < SAL + VEH). These results suggest that VGB can enhance the biphasic action of ethanol on locomotor activity toward its suppressive effects observed at higher ethanol doses.
To assess further the possibility that VGB enhanced biphasic ethanol effects toward suppression, a subsequent experiment summarized in Fig. 4c was completed using a borderline suppressive dose of ethanol (2.5 mg/kg) for C57BL/6J (B6) mice (Middaugh et al., 1992a) and the highest dose of VGB (600 mg/kg) used in the current experiments. The 3 (Drug Condition) Â 4 (Time Interval) ANOVA of these data also indicated significant effects of drug condition [F (2,15) = 34.94, P r 0.001] and its interaction with Time Interval [F (6,45) = 4.59, P r 0.001]; however, the pattern of change differed from that observed at the lower doses of ethanol and VGB. Subsequent post-hoc analyses indicated that, as expected, the 2.5 g/kg ethanol dose given by itself was neither stimulatory nor suppressive under the test conditions, compared with the SAL + VEH group. However, the combination of VGB and ethanol (VGB 600 + ethanol 2.5) produced a strong reduction in motor activity (P < 0.05) compared with either ethanol 2.5 by itself or the VEH Twenty-one hour consumption of 12% ethanol (g/kg), water (ml/kg), and food (mg/g). The data are averaged across drug days (DD) when mice were injected with either saline (n = 10) or vigabatrin (VGB) (200 mg/kg, n = 8 or 600 mg/kg, n = 10) and averaged across nondrug days (ND) when mice received no injections. VGB reduced ethanol consumption on DD and ND, whereas water consumption was markedly increased and food consumption was slightly, but significantly, increased only on ND. All values are means ± SEM (*P < 0.05 compared with vehicle). s.c., subcutaneously. controls. These results indicate that: (a) over the entire range of doses tested for its effect on ethanol consumption, VGB alone does not affect locomotion under the conditions of the experiment; (b) the most selective dose of VGB for ethanol reinforcement can interact with ethanol to shift the biphasic effects of ethanol on motor activity from stimulation toward depression without gross impairment of locomotion; and (c) high VGB doses can interact with slightly higher, but still nonactivity-suppressing doses of ethanol to markedly reduce locomotor activity.
Experiment-4: the effects of vigabatrin on the discriminative stimulus of ethanol
The impact of VGB on ethanol discrimination was tested using the most selective dose of VGB found to reduce ethanol reinforcement (200 mg/kg). The analysis was conducted using data from eight mice (of 17) that routinely demonstrated DI = 85% during training sessions, indicating successful discrimination of 1 g/kg ethanol from VEH. The primary data were percent responding on the ethanol-paired lever and are summarized in Fig. 5 . The 0.5 g/kg dosing series, yielding a total cumulative dose of 2.5 g/kg, was tested first and produced a discriminative stimulus that fully generalized to the ethanol-paired lever, evidenced by response ratios well above criterion performance levels (80%). In contrast, although the 0.25 g/kg dosing series produced a total cumulative dose of 1.25 g/kg (greater than the 1 g/kg training dose), it did not fully generalize to the ethanol-paired lever, indicated by mean responding below the criterion performance levels. Interestingly, pretreatment with VGB (200 mg/kg) increased discrimination ratios in both cumulative dosing series. For the 0.5 g/kg series, VGB-enhanced responding on the ethanol-paired lever occurred early in testing when ethanol cumulative doses were low, whereas for the 0.25 g/kg series, VGB increased discrimination ratios above criterion performance ( Fig. 5a and b ) later in the dosing series. These observations were confirmed by a 2 (VGB Dose) Â 2 (ethanol Dose) Â 6 (Cumulative Dose) RM ANOVA, revealing a significant three-way interaction [F (5,35) = 3.32, P < 0.02]. The three-way interaction was further analyzed using two-way ANOVAs and post-hoc analysis with pairwise comparisons. VGB administered 2.5 h before testing produced a leftward shift in the generalization curve for the 0.5 g/kg dosing series (VGB Dose Â Cumulative Dose Interaction: F (1,7) = 11.94, P r 0.01). Similarly, pretreatment with VGB before testing in the 0.25 g/kg dosing series resulted in full generalization to the subthreshold 0.25 g/kg ethanol dosing series [VGB Dose Â Cumulative Dose Interaction: F (1,7) = 8.22, P r 0.01]. In both cases, VGB enhanced the ethanol discriminative stimulus.
These data were further analyzed by calculating ED 50 values for individual mice using nonlinear regression analysis. The effects of VGB on ED 50 values (Fig. 5c ) were analyzed using paired t-tests according to the ethanol dosing series. Although VGB reduced the ED 50 of the 0.5 g/kg dosing series, the effect did not reach statistical significance [t (7) = 2.61, P = 0.07]. However, VGB did significantly reduce the ED 50 for the 0.25 g/kg dosing series (P < 0.05), indicative of a leftward shift in the ethanol generalization function. Taken together, these results indicate that VGB enhances the discriminativestimulus effects of ethanol.
Finally, at the conclusion of testing with the 0.25 g/kg injection series, BECs were measured. Surprisingly, it was found that BECs were 36% higher in mice injected 2.5 h earlier with VGB (55.2 ± 2.24 mg/dl) compared with SAL (40.3 ± 2.4 mg/dl), [t (8) = 7.43, P r 0.01]. Because these results suggested that VGB increased BECs, an additional experiment was conducted to confirm this result using a different group of C57BL/6J (B6) mice that were agematched, but ethanol naïve and not food restricted, as well as a higher VGB dose (400 mg/kg), followed by a single i.p. injection of ethanol (2 g/kg). Blood samples were collected at 5, 30, and 60 min following the ethanol injection. BEC values were as follows for VEH versus VGB: 5 min (224.6 ± 10.3 vs. 248 ± 7.7 mg/dl), 30 min (171.9 ± 3.6 vs. 195.3 ± 5.7 mg/dl), and 60 min (140.4 ± 11.4 vs. 154 ± 17.4 mg/dl). Again, VGB given s.c. 2.5 h earlier, were associated with elevated BECs (14-18%) at all time points, compared with SAL controls [F (1,34) = 13.4, P r 0.01].
These results indicate that VGB can slightly increase the plasma concentrations of ethanol.
Discussion
The present experiments indicate that, under several different conditions, VGB can dose-dependently and selectively reduce ethanol consumption compared with water or food. The VGB-induced reduction in ethanol consumption was accompanied by a shift toward water preference as evidenced by increased water consumption when the drug was present. This result indicates a bidirectional effect of VGB on ethanol compared with water reinforcement, underscoring the selectivity of VGB for reducing ethanol reinforcement. Further, because the lower, more selective doses of VGB (200 mg/kg) only reduced, rather than abolishing ethanol consumption, it is reasonable to hypothesize that VGB reduced ethanol consumption by potentiating the pharmacological effects of ethanol. To examine this possibility, the effects of coadministration of VGB and ethanol on locomotor activity and the discriminative-stimulus effects of ethanol were also examined. While not affecting locomotor activity if administered by itself, VGB (200 mg/kg) attenuated the locomotor-stimulating effects of a moderate ethanol dose, and a higher VGB dose (600 mg/kg) profoundly reduced locomotion when coadministered with a slightly higher ethanol dose. The combined effects of these two results suggest that VGB enhances the pharmacological action of ethanol, shifting it from the excitatory toward the depressive effects of its biphasic action. Consistent with its enhancement of ethanol effects on motor activity, we found that VGB (200 mg/kg) enhanced the discriminative-stimulus effects of ethanol as evidenced by leftward and upward shifts in ethanol generalization curves. The combined experiments indicate that irreversible inhibition of GABA transaminase can selectively reduce ethanol reinforcement, and that this may occur by an enhancement of the pharmacological effects of ethanol.
Using well-established operant procedures Middaugh et al., 2000b; Price and Middaugh, 2004; Nguyen et al., 2005) , we found that VGB dose-dependently reduced responding for ethanol reinforcement and ethanol intake. Importantly, a lower dose of VGB (200 mg/kg) for C57BL/6J (B6) mice selectively reduced ethanol, compared with food or water intake during short access periods (e.g. 15 min). In the present study, the motivational state of the mice was manipulated by testing under a prefeeding condition in which they were more likely to be hungry than thirsty, and also tested in a postfeeding condition in which they were more thirsty than hungry. C57BL/6J (B6) mice will lever press for ethanol reinforcement in the absence of hunger or thirst (Middaugh et al., 2000b) , but some degree of deprivation is necessary to assess responding for food and water over short periods of time. In addition, testing the same mice responding for ethanol, food, or water under similar motivational and experimental conditions as in Exp-1 (methods) strengthens conclusions about the comparative effects of VGB on responding for ethanol versus food or water reinforcement. Because the indirect mechanism of action of VGB is to cause a general increase in GABA levels and there is the potential for a broad suppression of behavior, the use of identical procedures in the current study was critical to determine the selectivity of VGB for ethanol reinforcement.
In addition to attaining access to ethanol by leverpressing, mice had free access to water during operant test periods in Exp-1 (methods), providing an additional opportunity to evaluate the selectivity of VGB for reducing ethanol reinforcement. Previous studies indicated that mice tested 1 h after being given their daily food ration, during which time water was removed to increase 'thirst', will immediately drink from the water spout during the first 3 min of an operant session but then shift to nearly exclusive lever responding for ethanol during the remainder of the session (Price and Middaugh, 2004) . In contrast, when mice are tested before being fed their daily ration, the amount of 'free' water consumed is negligible (Price and Middaugh, 2004) . Consistent with these prior observations, we found that mice consumed very little free water following VEH injection and this also was not affected by VGB 200 mg/kg, which significantly reduced ethanol intake. However, the higher VGB doses (400 and 600 mg/kg), while producing larger reductions in ethanol intake, increased the amount of water consumed from the sipper tube. Thus, the mice shifted their preference from ethanol to water.
The increases in appetitive behavior for water reinforcement following VGB treatment in our experiments with C57BL/6J (B6) mice are consistent with other reports. For example, the increased water consumption that accompanied the reduction in ethanol intake was also reported for AA rats (Wegelius et al., 1993) . Further, clinical reports indicate that some patients taking VGB for treatment of seizures experience gain weight (Tartara et al., 1992; Jallon and Picard, 2001) . In contrast to the clinical reports, VGB (300 mg/kg) administered daily reduced food consumption and bodyweight of adult and adolescent obese Zucker fatty rats and adolescent Sprague-Dawley rats (DeMarco et al., 2008) . The varied outcome of experiments across laboratories, species, and drug doses indicates the importance of these factors when comparing the effects of compounds on drug versus natural reinforcers. The current study and several previous reports indicate that VGB effects on responding for cocaine (Kushner et al., 1999) , nicotine (Paterson and Markou, 2002) , and ethanol (current study) all occurred at lower doses than required to reduce (or increase) responding for reinforcers such as food and water. Moreover, it was recently reported that microinjection of the GABA A agonist muscimol into the shell of the nucleus accumbens reduced ethanol consumption, but the same muscimol dose, given in the same location, actually increased food and sucrose consumption (Stratford and Wirtshafter, 2011) . From these reports as well as the current study, it is clear that the relative impact of GABAergic modulation using VGB (or other manipulations) on ethanol versus natural reinforcers is complex and further experimentation is necessary to understand the differences in these processes.
An important observation from the operant experiment indicated that VGB effects on ethanol reinforcement carried over to the next session and even to the next two sessions for the highest VGB dose. This prolonged effect is likely due to the irreversible inhibition of GABA transaminase by VGB (Jung et al., 1977; Gram et al., 1989; Rey et al., 1992) , resulting in long-term effects on ethanol reinforcement. These observations suggested that VGB would have long-term effects on ethanol consumption when evaluated using the free access (21 h), two-bottle choice procedure. Indeed, when administered every other day, VGB dose-dependently reduced ethanol intake on days when drug was administered, and the intervening days when VGB was not administered, indicating a long duration of action for VGB. Similar to Exp-1, VGB dosedependently increased water consumption; however, the increase was only noted on nontreatment days (Fig. 3) .
The results of the free access, two-bottle choice experiment clearly indicate that there was a shift in preference from ethanol to water with VGB treatment. In this experiment, there was also a small, but statistically significant, increase in food consumption with increasing VGB dose on nontreatment days. The bidirectional nature of VGB effects on ethanol versus food and water reinforcement suggests the intriguing possibility of distinct, but perhaps overlapping, GABAergic-mediated regulatory processes involved in pharmacological (drug) versus reinforcers such as food and water.
Given that VGB effects on GABA transaminase lead to increases in GABA, it is reasonable to postulate that some of the observed effects on the self-administration and consumption of ethanol might reflect an enhancement in the pharmacological effects of ethanol. The present set of experiments did provide evidence that the pharmacological effects of ethanol were enhanced by VGB. The biphasic action of ethanol, ranging from stimulation to depression of activity with increasing dose (Middaugh et al., 1989 (Middaugh et al., , 1992a (Middaugh et al., , 1992b , appeared to be shifted toward depression by administration of VGB. The stimulation produced by a 2 g/kg dose of ethanol, commonly observed in C57BL/6J (B6) mice, was attenuated by pretreatment with VGB 200 mg/kg (Fig. 4) , the dose most selective for reducing ethanol reinforcement. It is important to note that the combination of 2 g/kg ethanol and 200 mg/kg VGB did not grossly impair locomotion and mice given this combination were still quite ambulatory. In contrast, using a 2.5 mg/kg ethanol dose, which is on the borderline of stimulatory/depressive effects of ethanol for C57BL/6J (B6) mice (Middaugh et al., 1992a) , pretreatment with 600 mg/kg VGB considerably enhanced the depressive effects of ethanol. Although a complete dose-response function experiment for different combinations of VGB and ethanol will be necessary for a firm conclusion, our data suggest that VGB and ethanol interact to shift the locomotor effects of ethanol from stimulatory toward depressive.
On the basis of the argument that the discriminativestimulus effects of ethanol can provide a discriminative stimulus regarding the organism's level of intoxication (Hodge et al., 2006) another possible explanation for the observed VGB-induced reduction in ethanol self-administration is that VGB enhances the discriminative-stimulus effects of ethanol. This possibility was tested in our evaluation of VGB effects on ethanol discrimination using a cumulative dosing series (0.5 g/kg) that produced response ratios above criterion performance standards (i.e. > 80% on the ethanol-paired lever). VGB enhanced the discriminative-stimulus effects of ethanol at the beginning of the series when cumulative doses were low. At this ethanol dose, VGB appeared to shift the generalization curve to the left, although this was not statistically supported by analysis of ED 50 values. To evaluate further whether VGB enhanced the discriminative-stimulus effects of ethanol, we used a lower cumulative dosing series of ethanol (0.25 g/kg) that produced subcriterion levels of ethanol discrimination (i.e. < 80% on the ethanol-paired lever). Under the lower dosing conditions, VGB produced a significant leftward and upward shift in the generalization curve and significantly reduced the ED 50 values for ethanol discrimination, which strengthens the evidence that VGB can enhance the discriminative-stimulus effects of ethanol.
Because ethanol functions as an agonist at GABA A receptors (Burch and Ticku, 1980; Morrow et al., 1988a Morrow et al., , 1988b and VGB increases GABA concentrations (Jung et al., 1977; Gram et al., 1989; Rey et al., 1992) that act on these receptors, the interaction of VGB-induced increases in GABA concentrations with ethanol at GABA A receptors appears to be an especially important mechanism for the pharmacological effects we observed. This interaction can explain the reduced stimulation and the enhanced discrimination of ethanol by C57BL/6J (B6) mice, and both pharmacological effects are consistent with the reduced ethanol consumption following VGB pretreatment. In addition, we found that VGB produced slightly elevated BECs in the C57BL/6J (B6) mice used in these studies. For example, when coadministered with VGB, ethanol injections increased BECs by approximately 36% in the food-restricted mice used in the discrimination experiment and 18% in nondeprived mice. The mechanism for the altered ethanol pharmacokinetics following bolus injections is unclear and we are not aware of previous reports describing this effect. A more thorough examination of ethanol levels in the brain, liver, and perhaps other tissues will be required to establish possible mechanisms for these modest increases, especially in the context of self-administered ethanol. Clearly, the small increase in BECs provides an additional mechanism to explain some of the pharmacological effects we observed. Nevertheless, the altered pharmacokinetics of ethanol in combination with VGB do not completely explain the reduction noted in ethanol consumption. At the onset of a self-administration session, ethanol is not yet in the brain and brain ethanol concentrations increase gradually, peaking after consummatory behavior has ceased (Griffin et al., 2007 (Griffin et al., , 2009 ). This gradual increase is in contrast to the bolus injections given in the experiments in which we observed increased BECs with VGB. Therefore, it is plausible that the action of VGB to increase GABAergic neurotransmission in critical regulatory brain regions such as the nucleus accumbens may set the stage for a shift in preference away from ethanol to water (or food) before ethanol is present in the brain in pharmacologically relevant amounts. Thus, the VGB-induced increase in GABA concentrations that impact GABA A and perhaps also GABA B receptors remains an important mechanism in the effects reported in the present experiments.
In conclusion, we comprehensively examined the effects of VGB using several procedures designed to model specific aspects of ethanol-related behaviors using C57BL/6J (B6) mice. The experiments indicated that VGB produced dose-responsive reductions in ethanol self-administration and ethanol consumption. In contrast to the shorter duration of tiagabine in our earlier report (Nguyen et al., 2005) , the effect of VGB was observed for at least 48 h following s.c. injections of the drug. This is consistent with the irreversible inhibition of GABA transaminase by VGB and the enduring effects on GABA metabolism. Interestingly, the effects of VGB on water and food were in contrast to the effects on ethanol with increases in water and food consumption found after VGB treatment. VGB treatment also blunted the activitystimulating effects and discriminative-stimulus effects of ethanol, demonstrating that VGB augmented the pharmacological effects of ethanol at the GABA A receptor. Intriguingly, VGB treatment was associated with slight increases in BECs, providing a possible additional mechanism for its effects. Collectively, the data presented in the present report converge on the idea that VGB reduces ethanol consumption by reducing ethanol stimulation and enhancing the discriminative-stimulus properties of ethanol.
